Financials data is unavailable for this security.
View more
Year on year Cytosorbents Corp grew revenues 4.79% from 34.69m to 36.35m while net income improved from a loss of 32.81m to a smaller loss of 28.51m.
Gross margin | 62.71% |
---|---|
Net profit margin | -49.47% |
Operating margin | -58.51% |
Return on assets | -39.15% |
---|---|
Return on equity | -118.50% |
Return on investment | -49.80% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Cytosorbents Corp fell by 8.22m. Cash Flow from Financing totalled 14.47m or 39.82% of revenues. In addition the company used 21.66m for operations while cash used for investing totalled 936.24k.
Cash flow per share | -0.3236 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.2385 |
---|---|
Tangible book value per share | 0.2385 |
More ▼
Balance sheet in USDView more
Current ratio | 1.97 |
---|---|
Quick ratio | 1.58 |
Total debt/total equity | 1.06 |
---|---|
Total debt/total capital | 0.515 |
More ▼